Lv31
282 积分 2025-05-26 加入
FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS
15天前
已完结
Drug-induced Urinary Incontinence in Children: A Narrative Review
22天前
已完结
Gabapentin-Induced Overflow Urinary Incontinence: A Case Report and Review of the Literature
22天前
已完结
FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS
30天前
已完结
Cemiplimab-Induced Cytokine-Release Syndrome: Second Case Reported and Review of The Literature
1个月前
已完结
Cemiplimab-Induced Cytokine-Release Syndrome: Second Case Reported and Review of The Literature
1个月前
已关闭
Cemiplimab-Induced Cytokine-Release Syndrome: Second Case Reported and Review of The Literature
1个月前
已关闭
Cemiplimab-induced cytokine-release syndrome: second case reported and review of the literature
1个月前
已关闭
Analysis of the relationship between histamine H1 receptor antagonists and broad dementia events using the FAERS, JADER, and CVAR databases
2个月前
已完结
Postmarketing safety analysis of remimazolam
2个月前
已关闭
皖公网安备34019202002308
